Business Context and Reporting Period
Company: vTv Therapeutics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 26, 2015
Event: Unregistered sales of equity securities pursuant to Item 3.02.
Key Financial Metrics
This filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a specific equity transaction.
Material Changes
On August 26, 2015, the Company executed an exchange of securities with a former officer of its predecessor entities (vTvx Holdings I LLC and vTvx Holdings II LLC):
- Shares Exchanged: 1,344,186 shares of Class B Common Stock and 1,344,186 nonvoting common units of vTv Therapeutics LLC were exchanged for 1,344,186 shares of Class A Common Stock.
- Basis: The exchange was conducted on a one-for-one basis pursuant to the Exchange Agreement from the Company's initial public offering.
- Regulatory Status: Issued in reliance on the Section 4(a)(2) exemption from registration under the Securities Act of 1933.
- Remaining Pool: 23,655,814 shares of Class B Common Stock (and corresponding vTv Units) remain available for exchange into Class A Common Stock or cash at the Company's option.
Guidance, Outlook, and Risks
Lock-Up Agreement: The Former Officer is subject to a lock-up agreement regarding the newly issued Class A Common Stock, consistent with terms held by other Class B and vTv Unit holders from the IPO.
Outlook: The filing contains no management commentary, forward-looking guidance, or discussion of risks beyond the terms of the exchange agreement.
Investor Verification Checklist
- Verify the total outstanding share count of Class A and Class B Common Stock following this exchange.
- Confirm the specific terms of the lock-up agreement applicable to the Former Officer.
- Review the Exchange Agreement to understand the conditions under which the remaining 23,655,814 Class B shares may be converted to cash versus stock.